Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients

Keyphrases

• Acute Toxicity 75%
• Anorexia 25%
• Carboplatin 25%
• Cervical Cancer 50%
• Cervical Cancer Patients 100%
• Cervical Stromal Invasion 25%
• Chronic Toxicity 75%
• Common Toxicity Criteria 25%
• Concurrent Chemotherapy 75%
• Diarrhea 25%
• Disease-free 25%
• External Beam Radiotherapy 25%
• Gastrointestinal Toxicity 25%
• Genitourinary Toxicity 25%
• HDR Brachytherapy 50%
• Helical Tomotherapy 100%
• Hematotoxicity 50%
• In(III) 25%
• Intensity-modulated Radiotherapy 25%
• Intestinal Obstruction 25%
• Intracavitary 25%
• Invasive Cervical Cancer 100%
• Long-term Toxicity 25%
• Lymphovascular Invasion 25%
• Nausea 25%
• Pelvic Radiotherapy 25%
• Phase II Trial 100%
• Positive Lymph Nodes 25%
• Postoperative Radiotherapy 50%
• Progression-free Survival 25%
• Radiotherapy Alone 25%
• Taxol 25%
• Tumor Size 25%
• Vesicovaginal Fistula 50%
• Without Chemotherapy 100%

Medicine and Dentistry

• Anorexia 20%
• Carboplatin 20%
• Cervical Cancer 100%
• Chemotherapy 100%
• Chronic Toxicity 60%
• Diarrhea 20%
• Disease 20%
• External Beam Radiotherapy 20%
• Gastrointestinal Toxicity 20%
• High-Dose-Rate Brachytherapy 40%
• Intensity Modulated Radiation Therapy 20%
• Lymph Duct 20%
• Lymph Node 20%
• Nausea 20%
• Neoplasm 20%
• Paclitaxel 20%
• Pelvic Radiotherapy 20%
• Progression Free Survival 20%
• Radiation Therapy 60%
• Small Intestine Obstruction 20%
• Survival Rate 20%
• Tomotherapy 100%
• Vesicovaginal Fistula 40%